SCHEMBL8667850

SCHEMBL8667850

CCCN(CCCCN1CCC(N2C(=O)c3ccccc3C2=O)C1)C(=O)C1c2ccccc2-c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ BCHE P06276 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ DRD2 P14416 3/20 0.39
▸ DRD3 P35462 2/20 0.39
▸ HTR1A P08908 2/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ HTR7 P34969 1/20 0.39
▸ HRH1 P35367 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ OPRM1 P35372 2/20 0.37
▸ OPRK1 P41145 2/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ OPRL1 P41146 1/20 0.37
▸ CCR1 P32246 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8500612 0.92 MEN1 (0.44) L3MBTL1BCHEMEN1TSHRKMT2A
SCHEMBL8675063 0.77 L3MBTL1 (0.42) L3MBTL1MEN1TSHRKMT2ASMN1; SMN2
SCHEMBL8480408 0.76 TMEM97 (0.38) L3MBTL1BCHEMEN1TSHRKMT2A
SCHEMBL8485150 0.68 L3MBTL1 (0.41) L3MBTL1MEN1TSHRKMT2ANPSR1
SCHEMBL8480413 0.68 TMEM97 (0.35) L3MBTL1HTR2BOPRK1HTR2A
SCHEMBL8677227 0.67 HTR1A (0.46) MEN1TSHRKMT2ASMN1; SMN2NPSR1
SCHEMBL10485607 0.67 ACHE (0.59) DRD2DRD3OPRM1OPRK1OPRL1
SCHEMBL5633429 0.67 ACHE (0.59) DRD2DRD3OPRM1OPRK1OPRL1
SCHEMBL8667996 0.66 UTS2R (0.47) DRD2HTR7
SCHEMBL8483370 0.66 MTR (0.40) MEN1TSHRKMT2ASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827875-A PYRROLIDINE DERIVATIVES; ANTIATHEROSCLEROSIS AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-10-27 — — US disclosed
Send feedback